Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean M Nappi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Pharmacy Practice|October 25, 2013
A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemideJean M Nappi
Critical Care Nursing Clinics of North America|January 14, 2004
The role of B-type natriuretic peptide in heart failureJean M Nappi
American Journal of Pharmaceutical Education|June 22, 2013
An academician preparation program for pharmacy residentsJean M Nappi
Vascular Health and Risk Management|July 7, 2011
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failureJean M Nappi, Adam Sieg
The Annals of Pharmacotherapy|February 10, 2012
Assessment of prescribers' knowledge of the cost of medicationsBrittany Cogdill, Jean M Nappi
Clinical Therapeutics|December 25, 2003
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonistKelli L Davis, Jean M Nappi
Pharmacy Practice|August 22, 2014
A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritideJessica A Starr, Jean M Nappi
The Annals of Pharmacotherapy|July 5, 2003
Bosentan for the treatment of pulmonary arterial hypertensionKenneth W Kenyon, Jean M Nappi
The Annals of Pharmacotherapy|March 16, 2002
Role of race in the pharmacotherapy of heart failureJames S Kalus, Jean M Nappi
Pharmacotherapy|April 28, 2007
Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatmentChristine K Choy, Anne P Spencer, Jean M Nappi
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pharmacy Practice|October 25, 2013
A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemideJean M Nappi
Critical Care Nursing Clinics of North America|January 14, 2004
The role of B-type natriuretic peptide in heart failureJean M Nappi
American Journal of Pharmaceutical Education|June 22, 2013
An academician preparation program for pharmacy residentsJean M Nappi
Vascular Health and Risk Management|July 7, 2011
Aldosterone and aldosterone receptor antagonists in patients with chronic heart failureJean M Nappi, Adam Sieg
The Annals of Pharmacotherapy|February 10, 2012
Assessment of prescribers' knowledge of the cost of medicationsBrittany Cogdill, Jean M Nappi
Clinical Therapeutics|December 25, 2003
The cardiovascular effects of eplerenone, a selective aldosterone-receptor antagonistKelli L Davis, Jean M Nappi
Pharmacy Practice|August 22, 2014
A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritideJessica A Starr, Jean M Nappi
The Annals of Pharmacotherapy|July 5, 2003
Bosentan for the treatment of pulmonary arterial hypertensionKenneth W Kenyon, Jean M Nappi
The Annals of Pharmacotherapy|March 16, 2002
Role of race in the pharmacotherapy of heart failureJames S Kalus, Jean M Nappi
Pharmacotherapy|April 28, 2007
Prevalence of anemia in clinic patients with heart failure and cost analysis of epoetin treatmentChristine K Choy, Anne P Spencer, Jean M Nappi
Pageof 3